IP Library Granted Patent US 7,202,281
Granted Patent B2
US 7,202,281 · App. 10/749,436 · Granted Apr 10, 2007

Methods and compositions for reducing or eliminating post-surgical adhesion formation

Assignee: Synthemed, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,202,281
App. No.
10/749,436
Granted
Apr 10, 2007
Kind
B2
Abstract

The present invention relates to a method for reducing adhesions associated with post-operative surgery. The present method comprises administering or affixing a polymeric composition preferably comprising chain extended, coupled or crosslinked polyester/poly(oxyalkylene) ABA triblocks or AB diblocks having favorable EO/LA ratios to a site in the body which has been subjected to trauma, e.g. by surgery, excision or inflammatory disease. In the present invention, the polymeric material provides a barrier to prevent or reduce the extent of adhesions forming.

Claims (14)

1. A composition for use in reducing adhesions in a patient according to the structure:

where m and k are positive integers,

j is 0 to 4;

R 1 is H or CH 3 ;

R is ethylene, propylene or mixtures thereof;

R′ is a C 2 to C 12 alkylene group, a cycloalkyl or cycloalkyl-containing group, an aryl or aryl-containing group, 4,4′-diphenylmethane, toluene, naphthalene, 4,4′-dicyclohexylmethane, cyclohexyl, 3,3′-dimethylphenyl, 3,3′-dimethyl-diphenylmethane, 4,6′-xylylene, 3,5,5-trimethylcyclohexyl, 2,2,4-trimethylhexamethylene, p-phenylene or a poly(ethylene oxide) containing or poly(ethylene oxide) rich chain;

and K is a group derived from a compound which is unable to initiate ring opening polymerization of a starting lactone.

2. The composition according to claim 1 wherein K is a C 1 to C 12 alkyl group, an aryl group, an aralkyl group or a substituted C 1 to C 12 alkyl group, a substituted aryl group, a substituted aralkyl group, a C═C— containing group.

3. The composition according to claim 1 where K is methyl or ethyl.

4. The composition according to claim 1 wherein j is 0.

5. The composition according to claim 1 wherein R 1 is CH 3 .

6. The composition according to claim 1 wherein R is exclusively ethylene.

7. The composition according to claim 1 wherein R′ is a poly(ethylene oxide) rich chain.

8. The composition according to claim 1 wherein R′ is a 2,2,4-trimethylhexamethylene group.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2014
From: PATHFINDER CELL THERAPY, INC.
To: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
Reel/Frame 031905/0199 →
CHANGE OF NAME Recorded Jun 26, 2013
From: SYNTHEMED, INC
To: PATHFINDER CELL THERAPY, INC.
Reel/Frame 030694/0983 →
SECURITY AGREEMENT Recorded Sep 16, 2010
From: SYNTHEMED, INC.
To: PATHFINDER, LLC
Reel/Frame 025000/0207 →
CHANGE OF NAME Recorded Apr 29, 2009
From: LIFE MEDICAL SCIENCES, INC.
To: SYNTHEMED, INC.
Reel/Frame 022610/0392 →
Continuity (4)
Division 0968862500 · Oct 16, 2000
Division 0889080200 · Jul 11, 1997
Continuation In Part 0867876200 · Jul 11, 1996
Related Publication 20040156819A1 · Aug 12, 2004